bit.bio raises €92.7M Series B round

5 November 2021· Cambridge, United Kingdom· health, biotech, ai, b2b, deep_hardware

To accelerate the clinical development of the company's proprietary cell coding technology opti-ox and support the continued growth of the company's ioCells product portfolio.

Investors

LeadArch Ventures

Also participating

MetaplanetInc.TencentPuhua CapitalCharles River LaboratoriesForesite CapitalNational ResilienceMilky Way InvestmentsCasdin Capital

About bit.bio

Stage

Series C

Headquarters

Cambridge, United Kingdom

Founded

2016

Team Size

201–500

Sectors

healthbiotechaib2bdeep_hardware

https://www.bit.bio

Source: https://www.businesswire.com/news/home/20211105005477/en/bit.bio-Raises-in-Excess-of-100-Million-in-First-Close-of-Series-B-Financing